FindTrial
Sign In

Assessing the prevalence of Cancer pain in a Higher Cancer Centre

Cancer Pain Prevalence: A Prospective study at a Regional/Quarternary Cancer Centre - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075922
Enrollment
500
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C801- Malignant (primary) neoplasm, unspecified

Interventions

Control Intervention1: nil: nil

Sponsors

the Director, Cancer Institute (WIA)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients coming to Cancer Institute (WIA) with oncological ailment

Exclusion criteria

Exclusion criteria: paediatric patients, Patients with history of surgery within past 30 days, Patients with history of psychiatric disorder, Patients presenting to Emergency department, Patients unable to comprehend the questions

Design outcomes

Primary

MeasureTime frame
to estimate the prevalence of cancer related pain in patients presenting to Cancer Institute over 1 monthTimepoint: 30 days—

Secondary

MeasureTime frame
– to determine the type and severity of cancer pain in various typed of cancer. - to assess the effectiveness of the current analgesic practice in place.Timepoint: 30 days—

Countries

India

Contacts

Public ContactDR POORNA M S

Cancer Institute (WIA)

poorna.ms@gmail.com9916053879

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026